Chronotherapy with aspirin for reduction of cardiovascular disease
Phase 4
Completed
- Conditions
- 10011082cardiovasculaire aandoeningencardiovascular diseases
- Registration Number
- NL-OMON55498
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 328
Inclusion Criteria
patients who already use low-dose aspirin for secondary prevention of
cardiovascular events and use a multidose drug dispensing
Exclusion Criteria
Insufficient knowledge of the Dutch language
Patients currently participating in another (clinical) trial or study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method